Macquarie Group LTD Bioventus Inc. Transaction History
Macquarie Group LTD
- $87.4 Billion
- Q1 2024
A detailed history of Macquarie Group LTD transactions in Bioventus Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 1,809 shares of BVS stock, worth $10,401. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,809Holding current value
$10,401% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BVS
# of Institutions
89Shares Held
35.7MCall Options Held
167KPut Options Held
126K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$74.9 Million19.68% of portfolio
-
Juniper Investment Company, LLC New York, NY6.83MShares$39.3 Million18.22% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT5.81MShares$33.4 Million1.94% of portfolio
-
Sv Health Investors, LLC Boston, MA1.49MShares$8.56 Million32.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.22MShares$7.01 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $355M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...